Free Trial

Procter & Gamble (PG) Stock Forecast & Price Target

Procter & Gamble logo
$158.73 -3.37 (-2.08%)
As of 01/10/2025 03:58 PM Eastern

Procter & Gamble - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
7
Buy
16

Based on 23 Wall Street analysts who have issued ratings for Procter & Gamble in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 23 analysts, 7 have given a hold rating, 14 have given a buy rating, and 2 have given a strong buy rating for PG.

Consensus Price Target

$179.75
13.24% Upside
According to the 23 analysts' twelve-month price targets for Procter & Gamble, the average price target is $179.75. The highest price target for PG is $209.00, while the lowest price target for PG is $161.00. The average price target represents a forecasted upside of 13.24% from the current price of $158.73.
Get the Latest News and Ratings for PG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Procter & Gamble and its competitors.

Sign Up

PG Analyst Ratings Over Time

TypeCurrent Forecast
1/13/24 to 1/12/25
1 Month Ago
12/14/23 to 12/13/24
3 Months Ago
10/15/23 to 10/14/24
1 Year Ago
1/13/23 to 1/13/24
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
14 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$179.75$180.45$176.21$166.41
Forecasted Upside13.24% Upside5.48% Upside2.07% Upside10.50% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

PG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Procter & Gamble Stock vs. The Competition

TypeProcter & GambleConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.78
2.49
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside13.24% Upside49.55% Upside16.71% Upside
News Sentiment Rating
Positive News

See Recent PG News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/7/2025Wells Fargo & Company
3 of 5 stars
 Lower TargetOverweight ➝ Overweight$190.00 ➝ $176.00+8.44%
12/27/2024DA Davidson
3 of 5 stars
L. Weiser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$209.00 ➝ $209.00+23.28%
10/21/2024Morgan Stanley
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$174.00 ➝ $191.00+12.88%
10/21/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$180.00 ➝ $183.00+8.25%
10/21/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingSector Perform ➝ Sector Perform$164.00 ➝ $164.00-3.77%
10/4/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Zamacona
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
9/30/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Lieberman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$163.00 ➝ $163.00-6.08%
9/24/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$174.00+0.13%
9/19/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$179.00 ➝ $186.00+8.84%
8/29/2024DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$190.00+12.36%
8/23/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Badishkanian
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/1/2024Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Widjaja
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$182.00 ➝ $175.00+5.03%
7/23/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$189.00+12.31%
7/22/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$157.00 ➝ $161.00-4.14%
7/17/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$171.00 ➝ $176.00+4.13%
7/10/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$177.00 ➝ $190.00+13.96%
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$187.00+11.14%
4/25/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$180.00 ➝ $185.00+13.49%
3/11/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$160.00 ➝ $175.00+9.14%
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$168.00+5.70%
1/24/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$172.00 ➝ $178.00+15.85%
1/24/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$170.00 ➝ $175.00+13.65%
10/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$162.00 ➝ $153.00+7.02%
9/22/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$179.00+17.64%
9/8/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Andersen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
8/1/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$170.00 ➝ $175.00+11.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:54 AM ET.


Should I Buy Procter & Gamble Stock? PG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, January 3, 2025. Please send any questions or comments about these Procter & Gamble pros and cons to contact@marketbeat.com.

Procter & Gamble
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Procter & Gamble:

  • Procter & Gamble has a strong institutional ownership, with 65.77% of its stock held by institutional investors, indicating confidence in the company's stability and growth potential.
  • The company has recently seen significant increases in share ownership from various institutional investors, such as Geode Capital Management, which raised its position by 7.0%, suggesting positive market sentiment.
  • Procter & Gamble's stock is currently valued at approximately $165.00, reflecting its robust market performance and potential for future appreciation.
  • Recent strategic investments by firms like Franklin Resources, which increased its holdings by 10.2%, highlight the company's attractiveness to large investors, often seen as a bullish signal.
  • The diverse product segments of Procter & Gamble, including Beauty, Grooming, and Health Care, provide a balanced revenue stream, reducing risk associated with reliance on a single market segment.

Procter & Gamble
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Procter & Gamble for these reasons:

  • Insider selling has been notable, with 83,080 shares sold recently, which could indicate a lack of confidence from those closest to the company.
  • Despite recent growth, the company faces intense competition in the consumer goods sector, which could pressure margins and impact profitability.
  • Procter & Gamble's stock price may be perceived as high relative to its earnings, leading to concerns about overvaluation in a fluctuating market.
  • Changes in consumer preferences and economic conditions can adversely affect sales, particularly in discretionary segments like Beauty and Grooming.
  • The company's reliance on retail distribution channels makes it vulnerable to shifts in retail trends and potential disruptions in supply chains.

PG Forecast - Frequently Asked Questions

According to the research reports of 23 Wall Street equities research analysts, the average twelve-month stock price forecast for Procter & Gamble is $179.75, with a high forecast of $209.00 and a low forecast of $161.00.

23 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Procter & Gamble in the last year. There are currently 7 hold ratings, 14 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PG shares.

According to analysts, Procter & Gamble's stock has a predicted upside of 13.24% based on their 12-month stock forecasts.

Over the previous 90 days, Procter & Gamble's stock had 1 upgrade by analysts.

Procter & Gamble has been rated by research analysts at DA Davidson, Evercore ISI, Morgan Stanley, Royal Bank of Canada, and Wells Fargo & Company in the past 90 days.

Analysts like Procter & Gamble more than other "consumer staples" companies. The consensus rating for Procter & Gamble is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how PG compares to other companies.


This page (NYSE:PG) was last updated on 1/12/2025 by MarketBeat.com Staff
From Our Partners